Published date: 26 January 2018
Last edited date: 26 January 2018
This notice was replaced on 26 January 2018
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Future opportunity (published 26 January 2018)
Closed future opportunity - This means that a potential contract has passed its approach to market date. A buyer can choose to consider any supplier interest or convert this notice into an opportunity ready for live procurement.
Contract summary
Industry
Blood coagulants - 33141530
Location of contract
North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West
Value of contract
£8,100,000
Procurement reference
CM/PHS/14/5437
Published date
26 January 2018
Approach to market date
1 February 2018
Contract start date
1 July 2018
Contract end date
30 June 2019
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
Promthrombin Complex Concentrate (PCC)
More information
Spend profile
| Financial year | Budget |
|---|---|
| 2018/2019 | £6,075,000 |
| 2019/2020 | £2,025,000 |
Additional text
-
The product outlined in this future opportunity notice has been incorporated into the OPEN current future opportunity notice for 'Bleeding Disorders' (CM/PHS/15/5499) - hence this notice has been withdrawn.
About the buyer
Address
Commercial Medicines Unit - NHS England
2nd Floor, Rutland House
Runcorn
WA7 2ES
England
Share this notice
All content is available under the
